Data sharing uncovers five new risk genes for Alzheimer's disease

Analysis of genetic data from more than 94,000 individuals has revealed five new risk genes for Alzheimer’s diseas...

March 4, 2019 | Monday | News
Adagene to evaluate dynamic precision library platform with Celgene

China based Adagene, Inc., an innovative antibody discovery and engineering company, has announced a multi-target platfo...

March 4, 2019 | Monday | Regulatory
Link between GSL antigens and tumor survival in breast cancer found in a new research

A team led by Dr. Chi-Huey Wong, Distinguished Research Fellow, Academia Sinica in Taiwan, in collaboration with OBI sci...

February 19, 2019 | Tuesday | News
Chipscreen Biosciences unites with Innovent for colorectal cancer therapy

Chipscreen Biosciences, a leading integrated Chinese biotech company specialized in discovery and development of novel s...

February 18, 2019 | Monday | News
Singapore researchers reveal role of anti-parasitic drug in treating cancer

Scientists from A*STAR’s Institute of Molecular and Cell Biology (IMCB) have discovered that niclosamide, an FDA-a...

February 15, 2019 | Friday | News
Researchers develop potential therapeutic model for Parkinson's disease

Parkinson's disease (PD) is the second most common neurodegenerative disorder, implicating 10 million people worldwide b...

February 12, 2019 | Tuesday | News
Duke-NUS researchers reveal novel immune study on dengue

Researchers at Duke-NUS Medical School have demonstrated for the first time a physical interaction between two types of ...

February 8, 2019 | Friday | News
NUS researchers study nanoparticles' role in cancer metastasis

Nanoparticles can be found in processed food (e.g. food additives), consumer products (e.g. sunscreen) and even in medic...

February 4, 2019 | Monday | News
Researchers in Japan develop strategy to strengthen skeletal muscles

Hokkaido University researchers have developed a strategy to fabricate materials that become stronger in response to mec...

February 1, 2019 | Friday | News
Alvotech raises $300mn to further biosimilar development

Alvotech has successfully raised US$300 million through a private bond offering. Net proceeds from the capital raised ...

January 24, 2019 | Thursday | News
Novel device by NUS aids in muscle recovery

A team of NUS researchers has developed a novel medical device capable of harnessing a magnetic field to make muscle reh...

January 24, 2019 | Thursday | News
I-Mab Biopharma gets USFDA IND nod for antibody TJD5

China-based clinical stage biopharmaceutical company, I-Mab Biopharma, exclusively focused on the development of innovat...

January 23, 2019 | Wednesday | News
Mechanical stress may affect normal bone development

The bone matrix contains various proteins, namely, collagen and other non-collagenous proteins. Osteoblasts are responsi...

January 21, 2019 | Monday | News
Branched-Chain amino acids can regulate progression of Cancer: Research

Researchers at A*STAR's Singapore Bioimaging Consortium (SBIC) have discovered that branched-chain amino acids (BCAAs) i...

January 21, 2019 | Monday | News
Ribon Therapeutics raises $65M

Ribon Therapeutics, a biotechnology company developing first-in-class therapeutics targeting novel enzyme families activ...

January 7, 2019 | Monday | News
Tizona Therapeutics appoints Scott Clarke as CEO

US based biotech company, Tizona Therapeutics has announced that Scott Clarke has joined the company as its chief execut...

January 5, 2019 | Saturday | News
Betta Pharma uses ProBioGen's technology for cancer treatment

ProBioGen AG, a premier service & technology provider for complex therapeutic antibodies and glycoproteins, announce...

January 3, 2019 | Thursday | News
Roswell Biotech secures $32 million series A financing round

Roswell Biotechnologies, Inc., the pioneer in the development of a molecular electronics platform for DNA Sequencing, ha...

January 3, 2019 | Thursday | News
Innovent, Eli Lilly announce co-development of Tyvyt

Innovent Biologics and Eli Lilly and Company have jointly announced that the co-developed Tyvyt (fully human anti-PD-1 t...

December 28, 2018 | Friday | News
Researchers discover new compound to treat breast cancer

A novel compound against breast cancer improves the efficacy of standard cancer treatment and shows superior tolerabilit...

December 13, 2018 | Thursday | News
Gilead names Daniel O'Day as Chairman and CEO

Gilead Sciences Inc. a research-based biopharmaceutical company that discovers, develops and commercializes innovative m...

December 11, 2018 | Tuesday | News
Trianni, MacroGenics enter into a license agreement

Trianni, Inc. and MacroGenics, Inc. has announced that they have entered into a license agreement for The Trianni Mouse,...

December 8, 2018 | Saturday | News
Australian researchers develop novel technology for cancer detection

A group of researchers from the University of Queensland, Australia has developed a new method that will enable quick an...

December 5, 2018 | Wednesday | News
Marmosets viable in vivo models for developing immune-based therapies

Singapore – Scientists from A*STAR’s Singapore Immunology Network (SIgN) and Singapore Bioimaging Consortium...

November 26, 2018 | Monday | News
Eureka Therapeutics publicizes preclinical study validating ARTEMIS Platform

Eureka Therapeutics has announced publication in Cell Discovery validating its ARTEMIS antibody-TCR (AbTC...

November 22, 2018 | Thursday | News